journal article·2017-05-10

pH Triggered Size Increasing Gene Carrier for Efficient Tumor Accumulation and Excellent Antitumor Effect

Zhaopei Guo, Jie Chen, Lin Lin, Xiuwen Guan, Pingjie Sun, Meiwan Chen, Huayu Tian, Xuesi Chen

Publisher page

Abstract

High efficiency and serum resistant capacity are important for gene carrier in vivo usage. In this study, transfection efficiency and cell toxicity of polyethylenimine (PEI) (branched, Mw = 25K) was remarkably improved, when mixed with polyanion (polyethylene glycol-polyglutamic acid (PEG-PLG) or polyglutamic acid (PLG)). Different composite orders of PEI, polyanion, and gene, for example, PEI is first complexed with DNA, and then with polyanion, or PEI is first complexed with polyanion, and then with DNA, were studied. Results showed that only the polyanion/PEI complexes exhibited additional properties, such as decreased pH, resulting in increased particle size, as well as enhanced serum resistance capability and improved tumor accumulation. The prepared gene carrier showed excellent antitumor effect, with no damage on major organs, which is suitable for in vivo gene antitumor therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Polymer Ecomaterials; Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao 999078, China

University of Chinese Academy of Sciences, Beijing 100049, P. R. China

Funding

National Natural Science Foundation of China

References (53)

Show source-provided references
1. Dachs G. U. · Oncol. Res. · 1997 · 9 · 313
2. 10.1016/j.gene.2013.03.13710.1016/j.gene.2013.03.137 ↗
3. 10.1002/jgm.112010.1002/jgm.1120 ↗
4. 10.1016/j.biomaterials.2008.12.04310.1016/j.biomaterials.2008.12.043 ↗
5. 10.1002/smll.20120248510.1002/smll.201202485 ↗
6. 10.1002/adhm.20120003310.1002/adhm.201200033 ↗
7. 10.1016/S0168-3659(99)00090-510.1016/S0168-3659(99)00090-5 ↗
8. 10.1038/sj.gt.330103910.1038/sj.gt.3301039 ↗
9. 10.1021/acsami.6b1016610.1021/acsami.6b10166 ↗
10. 10.1021/am507812310.1021/am5078123 ↗
11. 10.1016/j.biomaterials.2012.06.10410.1016/j.biomaterials.2012.06.104 ↗
12. 10.1021/ar200220t10.1021/ar200220t ↗
13. 10.1021/ja016062m10.1021/ja016062m ↗
14. 10.1016/j.biomaterials.2012.02.05710.1016/j.biomaterials.2012.02.057 ↗
15. 10.1002/jgm.59810.1002/jgm.598 ↗
16. 10.1016/j.jconrel.2010.10.02810.1016/j.jconrel.2010.10.028 ↗
17. 10.1002/mabi.20100030210.1002/mabi.201000302 ↗
18. 10.1002/mabi.20130021110.1002/mabi.201300211 ↗
19. 10.1002/mabi.20140004410.1002/mabi.201400044 ↗
20. 10.1007/s10118-015-1632-010.1007/s10118-015-1632-0 ↗
21. 10.1002/anie.20150869510.1002/anie.201508695 ↗
22. 10.1016/j.addr.2010.09.00110.1016/j.addr.2010.09.001 ↗
23. 10.1002/anie.20150950710.1002/anie.201509507 ↗
24. 10.1007/s11426-010-0108-x10.1007/s11426-010-0108-x ↗
25. 10.1007/s10118-016-1756-x10.1007/s10118-016-1756-x ↗
26. 10.1038/sj.gt.330188810.1038/sj.gt.3301888 ↗
27. 10.1021/acs.nanolett.6b0253610.1021/acs.nanolett.6b02536 ↗
28. 10.1038/nrc86510.1038/nrc865 ↗
29. 10.1038/nrn217510.1038/nrn2175 ↗
30. 10.1016/j.yexmp.2011.07.00710.1016/j.yexmp.2011.07.007 ↗
31. 10.1038/3588810.1038/35888 ↗
32. 10.1016/j.addr.2007.03.00510.1016/j.addr.2007.03.005 ↗
33. 10.1158/0008-5472.CAN-04-407810.1158/0008-5472.CAN-04-4078 ↗
34. 10.1158/1078-0432.CCR-04-120610.1158/1078-0432.CCR-04-1206 ↗
35. 10.1089/oli.2010.024110.1089/oli.2010.0241 ↗
36. 10.1021/nn301159a10.1021/nn301159a ↗
37. 10.1039/C3TB21333A10.1039/C3TB21333A ↗
38. 10.1021/nl900031y10.1021/nl900031y ↗
39. 10.1080/0039791990808604210.1080/00397919908086042 ↗
40. 10.1021/ja043644610.1021/ja0436446 ↗
41. 10.1016/j.biomaterials.2010.09.02110.1016/j.biomaterials.2010.09.021 ↗
42. 10.1016/j.jconrel.2004.11.00610.1016/j.jconrel.2004.11.006 ↗
43. 10.1002/mabi.20120034610.1002/mabi.201200346 ↗
44. 10.1016/j.biomaterials.2011.09.01110.1016/j.biomaterials.2011.09.011 ↗
45. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
46. 10.1016/j.jconrel.2007.08.00610.1016/j.jconrel.2007.08.006 ↗
47. 10.1002/jbm.a.3134310.1002/jbm.a.31343 ↗
48. 10.1021/nl803487r10.1021/nl803487r ↗
49. 10.1021/bm900266r10.1021/bm900266r ↗
50. 10.1016/j.ymthe.2005.03.03810.1016/j.ymthe.2005.03.038 ↗
51. 10.1021/bp070319o10.1021/bp070319o ↗
52. Moghimi S. M. · Pharmacol. Rev. · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
53. 10.1016/0169-409X(95)00026-410.1016/0169-409X(95)00026-4 ↗